#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital pseudarthrosis Acute graft versus host disease in intestine Kearns-Sayre syndrome Non-small cell lung cancer recurrent Mantle cell lymphoma Primary mediastinal large B-cell lymphoma Hydrocephalus Scedosporium infection Vulval cancer Cholestatic pruritus Undifferentiated sarcoma Mantle cell lymphoma stage III Astrocytoma malignant Diffuse large B-cell lymphoma recurrent Cardiac failure acute More trials…

    Learn about Rare Diseases

    Burkitt’s lymphoma Mucous membrane pemphigoid – Diagnostics Medulloblastoma recurrent – Diagnostics Gastrointestinal stromal tumour Netherton’s syndrome – Trials in Disease CADASIL – Basic Information IgA nephropathy Lennox-Gastaut syndrome – Diagnostics VEXAS syndrome – Basic Information CADASIL – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sacubitril Valsartan Revumenib [18F]DED Gadoquatrane Lisaftoclax Afimetoran Besilate Dihydrate Calcium Pantothenate Bp Allopurinol Latozinemab Glatiramer Acetate Rucaparib SELTOREXANT 19Cp02 Hydrocortisone Hemisuccinate FERUMOXTRAN-10 Thiotepa Simoctocog Alfa Canis Familiaris (553) ARLOCABTAGENE AUTOLEUCEL Ngi226 More therapies…

    Learn about Your Condition

    Pelvic venous thrombosis Breast cancer stage I Laryngeal cancer stage III Peritoneal neoplasm Deafness traumatic Childhood asthma Infertility male Procedural pain Haematological infection Vascular dementia Mental disorder Pouchitis Polycystic ovarian syndrome Elderly Aneurysm ruptured More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Safety and feasibility study of fecal microbiota transplant in stage II-III non-small cell lung cancer patients treated with durvalumab, carboplatin, paclitaxel and rifaximin

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Rifaximin
    • Carboplatin
    • Durvalumab
    Spain

  • Study of drug combination therapy for prevention of recurrent stroke in patients with acute ischemic stroke and atrial fibrillation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    • Ischaemic stroke
    Investigated Drugs:
    • Amiodarone Hydrochloride
    • Flecainide Acetate
    • Propafenone Hydrochloride
    Germany The Netherlands Spain

  • Study of dupilumab injections to reduce airway inflammation in adults aged 40-85 with chronic obstructive pulmonary disease

    Recruiting

    3 1 1
    Investigated Drugs:
    • Salbutamol
    • Dupilumab
    Austria Denmark France Germany Hungary Italy +4

  • Study of TYRA-300-B01 tablets in patients with low grade, intermediate risk non-muscle invasive bladder cancer who have FGFR3 gene changes

    Recruiting

    2 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma
    Investigated Drugs:
    • Tyra-300-B01
    France Italy Spain

  • Study of MTX-463 compared to placebo to assess its safety and effectiveness in adults with idiopathic pulmonary fibrosis

    Recruiting

    2 1 1
    Investigated Drugs:
    • Sodium Chloride
    • Glucose Monohydrate
    Belgium Croatia France Ireland The Netherlands Spain

  • Study of dapagliflozin to prevent heart complications during lymphoma treatment in patients receiving first-line therapy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Anaplastic large cell lymphoma T- and null-cell types
    • T-cell lymphoma
    • Follicular lymphoma
    Investigated Drugs:
    • Placebo
    Denmark
Previous Page
1 … 148 149 150 151 152 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!